Pharmaceuticals Supplements Medical Devices
About Us Careers FAQ All Insights
Privacy Policy Terms of Service
Thai FDA Drug Registration Local Authorized Representative (LAR) & Importer of Record (IOR) Dossier Preparation, ACTD Submissions & Thai Labeling GMP Compliance Consulting Post-Approval Lifecycle Management Pharmacovigilance Government Fee Schedule Pharmaceutical Insights
Thai FDA Supplement Registration Local Importer & Orr.7 Import License GMP Requirements for Supplement Manufacturers Labeling & Health Claims Ingredient Approval & Novel Food Advertising Approval & the Kho Or Permit Supplement Insights
Thai FDA Medical Device Registration Device Classification: AMDD Classes 1-4 Local License Holder & Establishment Licensing Technical File & CSDT Preparation Labeling Requirements: B.E. 2568 (2025) Medical Device Insights
Email WhatsApp (+66) 082.208.2460
Email WhatsApp (+66) 082.208.2460

Medical Device Regulatory
Insights

Regulatory analysis for foreign medical device manufacturers and importers entering Thailand. All articles draw on Thai FDA guidance, the Medical Device Act B.E. 2551 (2008), and the ASEAN Medical Device Directive.

← All Insights

Medical Device Regulatory News

US FDA Finalizes Human Factors Guidance for Device Submissions: Three-Category Framework Established FDA established a risk-based three-category framework for human factors documentation in device submissions. The standard will reach Thai FDA CSDT review expectations within the next one to two regulatory cycles.
May 29, 2026
MDA Malaysia and Thai FDA Launch Full Bilateral Medical Device Reliance Programme MDA and Thai FDA launched their full bilateral reliance programme for Class B, C, and D devices on May 1, 2026. MDA-approved devices bypass external expert review at Thai FDA, the fastest current fast-track into Thailand.
May 1, 2026
IMDRF N93: The International AI Medical Device Lifecycle Framework Open for Public Consultation IMDRF opened consultation on N93, its AI device lifecycle framework, through July 10, 2026. The document will directly inform the next iteration of Thai FDA's AI device requirements. Comments accepted until July 10.
April 10, 2026
Malaysia MDA and Thai FDA Conduct Technical Training on SaMD, AI Devices, and Predetermined Change Control Plans Malaysia's MDA trained Thai FDA officials in Bangkok on SaMD classification, AI device frameworks, and PCCPs in April 2026, a direct signal of where Thai FDA's technical review capacity is heading.
April 8, 2026
IMDRF 29th Session Launches New AI/ML and IVD Working Groups The 29th IMDRF Management Committee Meeting in Singapore launched new working groups on AI/ML-enabled device principles and IVD clinical evidence. Thai FDA participates in IMDRF and typically adopts its guidance, signaling where Thailand's AI device and diagnostic requirements are headed.
March 9, 2026
Thai FDA Issues New Establishment Registration Forms Covering SaMD Storage Locations Thai FDA issued three B.E. 2569 notifications introducing revised establishment registration forms that explicitly cover standalone software storage locations. Companies manufacturing, importing, or selling medical devices including SaMD in Thailand must use the updated forms from May 1, 2026.
March 5, 2026
IMDRF Updates Adverse Event Terminology Standard for Medical Devices and IVDs IMDRF published the 2026 release of its adverse event terminology standard N43, updating alphanumerical codes across seven reporting categories. Device vigilance teams submitting incident reports to Thai FDA should verify their reporting taxonomy aligns with the updated codes.
March 3, 2026
IMDRF Publishes Regulatory Reliance Playbook for Medical Device Authorities IMDRF published a flexible playbook for building formal regulatory reliance programs covering the full medical device lifecycle. The guidance directly underpins bilateral reliance programs like the Malaysia-Thai FDA pilot launched the same month and signals the direction of ASEAN device harmonization.
February 26, 2026
Thai FDA Overhauls Medical Device Record-Keeping and Extends Annual Reporting Deadline Thailand's Ministry of Public Health revised medical device record-keeping criteria, shifting to electronic records and extending the annual deadline from March 31 to May 31. Most device companies will have reduced annual reporting obligations, while mercury and radiation-emitting devices now face quarterly requirements.
February 2, 2026
Malaysia MDA and Thai FDA Activate Three-Month Bilateral Device Reliance Pilot Malaysia's MDA and Thai FDA activated a three-month pilot from February 1, 2026 allowing Class B, C, and D device approvals from one authority to substitute for full review by the other. Device companies registered in Malaysia can use MDA approval to streamline Thai FDA registration.
February 1, 2026

Medical Device Regulatory Guides

Radiation-Emitting Medical Devices in Thailand Radiation-emitting medical devices in Thailand require compliance with both Thai FDA's medical device registration framework and the Office of Atoms for Peace's radiation safety requirements. This guide covers both regulatory frameworks, the licensing requirements, and how they interact for devices like X-ray equipment and therapeutic radiation systems.
ASEAN Medical Device Directive Harmonization and Thailand ASEAN's Medical Device Directive harmonization initiative is progressively aligning Thailand's medical device registration requirements with a common regional framework. This guide explains the AMDD, Thailand's current implementation status, and how harmonization affects registration strategy.
Sterile Medical Device Requirements in Thailand Sterile medical devices face additional registration and import requirements in Thailand, including sterility validation documentation and specific packaging and labeling standards. This guide covers the Thai FDA requirements that apply specifically to sterile devices and the most common deficiencies in sterility documentation.
Device Recall and Adverse Event Reporting in Thailand Medical device license holders must report adverse events and initiate formal recalls when device safety issues arise in the Thai market. This guide covers reporting timelines, the mandatory notification process, and the documentation Thai FDA requires through recall closure.
Good Distribution Practice for Medical Device Importers Thai FDA's GDP requirements for medical devices govern storage, handling, and distribution from the import point through to the end user. This guide covers the facility standards, temperature control requirements, and documentation practices that support GDP compliance for device importers.
Clinical Investigation Requirements for Medical Devices in Thailand Clinical investigations for medical devices in Thailand require Thai FDA authorization before any study involving human subjects may begin. This guide covers the authorization process, protocol requirements, ethics committee review, and GCP standards Thai FDA applies to device studies.
Advertising Medical Devices in Thailand Medical device advertising in Thailand requires prior approval from Thai FDA before any promotional material is disseminated. This guide covers the advertising permit process, permitted claim types, channel-specific requirements, and the enforcement consequences of advertising without approval.
Software as a Medical Device: Classification and Registration Software that qualifies as a medical device under Thai FDA's guidelines is subject to the same registration requirements as hardware devices. This guide covers the SaMD classification criteria, the registration pathway, and the specific technical documentation Thai FDA requires for software submissions.
Combination Products in Thailand Products that combine a medical device with a drug or biological component present classification challenges in Thailand's regulatory framework. This guide covers how Thai FDA determines the primary mode of action, which regulatory pathway applies, and the dossier requirements for combination products.
Custom-Made and Special Access Devices in Thailand Custom-made medical devices and devices accessed through Thailand's special access pathway follow different regulatory routes from standard registered devices. This guide covers the eligibility criteria, documentation requirements, and the conditions under which Thai FDA grants special access authorization.
Medical Device Labeling Requirements in Thailand Thai FDA requires medical device labels to carry Thai-language content meeting the mandatory elements specified under the Medical Device Act B.E. 2551 (2008), as amended by the Medical Device Act (No. 2) B.E. 2562 (2019). This guide covers the mandatory label elements, bilingual label requirements, and the labeling errors that most commonly trigger registration queries.
Free Sale Certificate Requirements for Medical Device Registration Thai FDA requires a Free Sale Certificate from the competent authority of the country of manufacture as part of the medical device import and registration documentation. This guide covers FSC requirements, accepted issuing authorities, and how the FSC integrates with the CSDT submission.
ISO 13485 Quality Management System Requirements for Thai FDA Registration Thai FDA requires evidence of a certified ISO 13485 quality management system from foreign manufacturers as part of the medical device registration dossier. This guide covers the certification requirements, accepted certification bodies, and how QMS evidence is structured in the CSDT.
Variation Applications for Registered Medical Devices Changes to a registered medical device's design, labeling, manufacturer, or distribution arrangement after registration require a variation application to Thai FDA. This guide covers which changes trigger variation, the application categories, and the documentation requirements.
Medical Device Classification in Thailand Thailand classifies medical devices into risk-based classes under the Medical Device Act B.E. 2551 (2008). This guide covers the classification criteria, the class determination process, and how classification affects the registration pathway and dossier requirements.
Post-Market Surveillance Obligations for Medical Devices Medical device license holders in Thailand must maintain post-market surveillance systems and report adverse events to Thai FDA within defined timeframes. This guide covers the surveillance obligations, reportable event categories, and the documentation standards Thai FDA expects.
IVD Classification in Thailand In vitro diagnostic devices are classified separately from general medical devices in Thailand's regulatory framework. This guide covers the IVD classification criteria, the ASEAN IVD regulatory framework Thailand applies, and the registration requirements that apply at each class.
Import Permit Requirements for Medical Devices in Thailand Medical devices imported into Thailand require an import permit issued per product and per consignment under the Medical Device Act. This guide covers the permit application process, the documentation Thai FDA requires, and how the import permit interacts with the device registration.
Clinical Data Requirements for Class 3 Medical Devices Class III medical devices in Thailand require clinical evidence demonstrating safety and performance as part of the CSDT registration dossier. This guide covers the clinical data standards Thai FDA applies, what types of studies are accepted, and when clinical evidence can be waived.
CE Marking and FDA Clearance for Thai Device Registration Thai FDA evaluates whether CE marking or US FDA clearance can substitute for local clinical data in a CSDT submission. This guide covers the reliance framework, the conditions under which foreign approvals are accepted, and what additional Thai-specific data is still required.

Medical Device Regulatory Services

Medical Device Regulatory Overview
Device Classification We determine the correct risk class for your device under Thailand's Medical Device Act and advise on the registration pathway, dossier requirements, and timeline before any submission work begins.
Technical File and CSDT Preparation We prepare the Common Submission Dossier Template in-house, structured to Thai FDA's format requirements, with clinical data assessment and Thai-language label preparation included.
Local License Holder VeroPharma Group holds the establishment licenses required to serve as local license holder, bearing full legal responsibility for your registered device on the Thai market.